OTR Therapeutics raises $100 million in Series A financing, led by True Light Capital, to advance early innovations into transformative therapies.
Amount Raised
$100 Million
Round Type
Series A
ShanghaiBiotechnologyHealth CareTherapeuticsInvestors
Description
OTR Therapeutics announced the successful completion of a $100 million Series A financing. The round was backed by investors including True Light Capital, LAV, Pfizer Ventures, and Sirona Capital. The proceeds will advance OTR's pipeline for immunology, oncology, and expand its R&D capabilities. OTR is also acquiring a preclinical program targeting neurological diseases.
Quick answer
OTR Therapeutics raised $100 Million in a Series A round, dated December 5, 2025. Investors: Lav, Pfizer Ventures, Sirona Capital and True Light Capital. OTR Therapeutics is based in Shanghai, Shanghai, China.
- How much did OTR Therapeutics raise?
- OTR Therapeutics raised $100 Million in a Series A round on December 5, 2025.
- Who invested in OTR Therapeutics?
- Lav, Pfizer Ventures, Sirona Capital and True Light Capital are named as investors in this round.
- What does OTR Therapeutics do?
- OTR Therapeutics is a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for critical diseases with high unmet medical needs.
- Where is OTR Therapeutics based and how big is it?
- OTR Therapeutics is based in Shanghai, Shanghai, China. Fundz records about 8 employees.
- Who are the decision-makers at OTR Therapeutics?
- Fundz holds 1 contact at OTR Therapeutics, including the Co-founder, CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as OTR Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.5M on January 14, 2026.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
- Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
- AirNexis Therapeutics raised $62M on January 9, 2026.
- Aurora Therapeutics raised $16M (Seed) on January 9, 2026.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
Who to call at OTR Therapeutics, and when
A new round usually means OTR Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OTR Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OTR Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OTR Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OTR Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOTR Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.